Overall market sentiment has been down on Curaleaf Holdings Inc (CURLF) stock lately. CURLF receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.
Curaleaf Holdings Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on CURLF!
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With CURLF Stock Today?
Curaleaf Holdings Inc (CURLF) stock is trading at $13.33 as of 2:05 PM on Friday, Jul 16, a loss of -$0.35, or -2.56% from the previous closing price of $13.68. The stock has traded between $13.31 and $14.00 so far today. Volume today is light. So far 319,260 shares have traded compared to average volume of 483,951 shares.
More About Curaleaf Holdings Inc
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 23 states, including the assets from the Cura Select and Grassroots acquisitions. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.
Click Here to get the full Stock Report for Curaleaf Holdings Inc stock.